Agilent Technologies (NY:A)

This W.W. Grainger Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Wednesday

October 08, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years

October 07, 2025

Via Benzinga

3 Healthcare Stocks We Think Twice About

October 03, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent...

Topics Stocks

Where Agilent Technologies Stands With Analysts

August 28, 2025

Via Benzinga

Assessing Agilent Technologies: Insights From 7 Financial Analysts

October 02, 2025

Via Benzinga

Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Topics Artificial Intelligence Economy Government

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years

October 01, 2025

Via Benzinga

Topics Government

U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector

September 30, 2025

The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series...

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

Topics Artificial Intelligence Economy World Trade

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement...

Topics Artificial Intelligence Economy Government

Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma

September 30, 2025

Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility

Topics Artificial Intelligence Economy Government

September 30, 2025

As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move...

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

Topics Economy Government Supply Chain

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Topics Government

Discover which S&P500 stocks are making waves on Tuesday.

September 30, 2025

Via Chartmill

Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening

September 30, 2025

Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing

September 29, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Question

September 29, 2025

Looking Into Agilent Technologies's Recent Short Interest

September 23, 2025

Via Benzinga

Agilent Announces Cash Dividend of 24.8 Cents per Share

September 17, 2025

Agilent Technologies Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)

September 15, 2025

Via Benzinga

Agilent to Participate in 2025 Bank of America Global Healthcare Conference

September 11, 2025

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification

September 09, 2025

Nasdaq looks primed to continue its run of stomping the market.

1 Magnificent S&P 500 Dividend Stock I'm Buying Right Now

September 07, 2025

Via The Motley Fool

Topics Artificial Intelligence Fraud Stocks

Research Tools & Consumables Stocks Q2 Teardown: Agilent (NYSE:A) Vs The Rest

September 04, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at research tools & consumables stocks,...

Topics Economy

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

September 03, 2025

Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

September 02, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Exploring the top movers within the S&P500 index during today's session.

August 28, 2025

Via Chartmill

Agilent (A) Stock Trades Up, Here Is Why

August 28, 2025

Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.7% in the morning session after the company reported better-than-expected revenue in its second-quarter 2025 results and...

Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Topics Artificial Intelligence Economy Stocks

Discover which S&P500 stocks are making waves on Thursday.

August 28, 2025

Via Chartmill

A Q3 Deep Dive: Pharma and Materials Demand Drive Growth, Margin Pressures Persist

August 28, 2025

Life sciences tools company Agilent Technologies (NYSE:A) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.1% year on year to $1.74 billion. On top of that, next quarter’s revenue...